Boston Scientific Statistics

Total Valuation

ETR:BSX has a market cap or net worth of EUR 123.16 billion. The enterprise value is 132.93 billion.

Market Cap	123.16B
Enterprise Value	132.93B

Important Dates

The next estimated earnings date is Wednesday, April 23, 2025.

Earnings Date	Apr 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+1.53%
Shares Change (QoQ)	+0.19%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.47B

Valuation Ratios

The trailing PE ratio is 68.81.

PE Ratio	68.81
Forward PE	n/a
PS Ratio	7.61
PB Ratio	5.80
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 34.43, with an EV/FCF ratio of 52.03.

EV / Earnings	74.27
EV / Sales	8.98
EV / EBITDA	34.43
EV / EBIT	50.11
EV / FCF	52.03

Financial Position

The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.51.

Current Ratio	1.08
Quick Ratio	0.46
Debt / Equity	0.51
Debt / EBITDA	2.57
Debt / FCF	4.24
Interest Coverage	9.84

Financial Efficiency

Return on equity (ROE) is 8.89% and return on invested capital (ROIC) is 6.02%.

Return on Equity (ROE)	8.89%
Return on Assets (ROA)	5.03%
Return on Invested Capital (ROIC)	6.02%
Return on Capital Employed (ROCE)	9.10%
Revenue Per Employee	305,206
Profits Per Employee	33,770
Employee Count	53,000
Asset Turnover	0.45
Inventory Turnover	2.00

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +29.38% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+29.38%
50-Day Moving Average	93.73
200-Day Moving Average	83.15
Relative Strength Index (RSI)	36.83
Average Volume (20 Days)	233

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.59

Income Statement

In the last 12 months, ETR:BSX had revenue of EUR 16.18 billion and earned 1.79 billion in profits. Earnings per share was 1.21.

Revenue	16.18B
Gross Profit	11.07B
Operating Income	2.90B
Pretax Income	2.20B
Net Income	1.79B
EBITDA	4.13B
EBIT	2.90B
Earnings Per Share (EPS)	1.21

Full Income Statement

Balance Sheet

The company has 399.88 million in cash and 10.85 billion in debt, giving a net cash position of -10.45 billion.

Cash & Cash Equivalents	399.88M
Total Debt	10.85B
Net Cash	-10.45B
Net Cash Per Share	n/a
Equity (Book Value)	21.25B
Book Value Per Share	14.26
Working Capital	503.23M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.32 billion and capital expenditures -763.06 million, giving a free cash flow of 2.55 billion.

Operating Cash Flow	3.32B
Capital Expenditures	-763.06M
Free Cash Flow	2.55B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 68.41%, with operating and profit margins of 17.93% and 11.07%.

Gross Margin	68.41%
Operating Margin	17.93%
Pretax Margin	13.63%
Profit Margin	11.07%
EBITDA Margin	25.50%
EBIT Margin	17.93%
FCF Margin	15.79%

Dividends & Yields

ETR:BSX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.53%
Shareholder Yield	-1.53%
Earnings Yield	1.45%
FCF Yield	2.07%

Stock Splits

The last stock split was on November 6, 2003. It was a forward split with a ratio of 2.

Last Split Date	Nov 6, 2003
Split Type	Forward
Split Ratio	2

Scores

ETR:BSX has an Altman Z-Score of 4.66.

Altman Z-Score	4.66
Piotroski F-Score	n/a